Kumar Sambamurti
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (6)
Year:
2026
Year:
2025
Patients with Alzheimer's disease (AD) have a decreased incidence of cancer, with a cross-sectional analysis of a nationwide sample of adults finding 21-fold higher odds of cancer diagnosis in non-AD individuals compared with those with AD. In this study, we demonstrated that mitochondrial localization of AD-associated amyloid-β precursor protein (APP) and its cleavage product amyloid-β 40, but not mutant APP that lacks a mitochondrial localization signal, inhibits lipid stress–mediated hyperactive mitophagy in aging T cells, improving their antitumor functions. Growth of melanoma xenograft or carcinogen-induced oral cancer models was highly reduced in AD mice. Additionally, adoptive cell transfer–based immunotherapy using aging T cells isolated from AD mice suppressed tumor growth. The metabolic signature of stress-dependent mitophagy in T cells showed fumarate depletion, which was linked to decreased succination of Parkin and enhanced mitochondrial damage. Mechanistically, APP interaction with the TOMM complex at the outer mitochondrial membrane attenuated trafficking of ceramide synthase CerS6 to mitochondria in aging AD T cells, preventing ceramide-dependent mitophagy. Thus, APP restored mitochondrial fumarate metabolism and Parkin succination, improving antitumor functions of AD T cells in vitro and in vivo . Exogenous fumarate supplementation or healthy AD mitochondria transfer functionally mimicked the AD/APP phenotype in aging T cells, enhancing their antitumor activity to control tumor growth. Moreover, T cells isolated from aging donors showed elevated mitophagy with fumarate depletion, which was restored in T cells isolated from age-matched patients with AD. Together, these findings show that AD protects T cells against ceramide-dependent mitophagy and fumarate depletion to enhance antitumor functions. Significance: The reduced cancer risk in Alzheimer's disease patients is mediated by the amyloid-β 40 peptide, which inhibits aging-dependent mitophagy in T cells to improve antitumor immunity. See related commentary by Bieberich, p. 3579
Year:
2025
Year:
2022
Year:
2021
Year:
2020
Collaborators (10)
Besim Ogretmen
Professor
Medical University of South Carolina
Özgür Şahin
Professor and SmartState Endowed Chair
Medical University of South Carolina
Paramita Chakraborty
Research Assistant Professor
Medical University of South Carolina
Natalia Oleinik
Res. Assistant Professor
Medical University of South Carolina
Thomas Olsen
-
Onder Albayram
Assistant Professor
Medical University of South Carolina
Hanuma kumar Karnati
University of Nebraska Medical Center
Shikhar Mehrotra
Medical University of South Carolina
Kalyani Sonawane
Assistant Director of Data and Analytics
University of Texas School of Public Health
Ashish Deshmukh
Professor
Medical University of South Carolina
Make your next move.
Prepare your application
Review drafts before you send them.